Biotech News

Acadia Healthcare Announces First Quarter 2026 Results

Acadia Healthcare (ACHC)Acadia Healthcare2026-06-25 13:46 ESTEarnings

Company Increases Full Year 2026 Adjusted EBITDA and Adjusted EPS Guidance FRANKLIN, Tenn. --(BUSINESS WIRE)--Apr. 29, 2026-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026.

Open original release

Related news

Acadia Healthcare

Acadia Healthcare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States